文献

J-GLOBAL ID：201202202462797000   整理番号：12A1121945

肝細胞癌治療用の新規抗癌剤使用に関するガイドライン2010年最新版

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

著者 (40件)： KANEKO Shuichi (Novel Anticancer Agent Guideline Drafting Committee) ,  KANEKO Shuichi (Study Group on New Liver Cancer Therapies) ,  KANEKO Shuichi (Kanazawa Univ., Kanazawa) ,  FURUSE Junji (Novel Anticancer Agent Guideline Drafting Committee) ,  FURUSE Junji (Study Group on New Liver Cancer Therapies) ,  FURUSE Junji (Kyorin Univ. School of Medicine, Mitaka) ,  KUDO Masatoshi (Novel Anticancer Agent Guideline Drafting Committee) ,  KUDO Masatoshi (Study Group on New Liver Cancer Therapies) ,  KUDO Masatoshi (Kinki Univ., Higashiosaka) ,  IKEDA Kenji (Novel Anticancer Agent Guideline Drafting Committee) ,  IKEDA Kenji (Study Group on New Liver Cancer Therapies) ,  IKEDA Kenji (Toranomon Hospital, Tokyo) ,  HONDA Masao (Study Group on New Liver Cancer Therapies) ,  HONDA Masao (Kinki Univ., Higashiosaka) ,  NAKAMOTO Yasunari (Study Group on New Liver Cancer Therapies) ,  NAKAMOTO Yasunari (Fukui Univ., Fukui) ,  ONCHI Morikazu (Study Group on New Liver Cancer Therapies) ,  ONCHI Morikazu (Ehime Univ., Matsuyama) ,  SHIOTA Goshi (Study Group on New Liver Cancer Therapies) ,  SHIOTA Goshi (Tottori Univ. Graduate School of Medicine, Tottori) ,  YOKOSUKA Osamu (Study Group on New Liver Cancer Therapies) ,  YOKOSUKA Osamu (Chiba Univ., Chiba, JPN) ,  SAKAIDA Isao (Study Group on New Liver Cancer Therapies) ,  SAKAIDA Isao (Yamaguchi Univ. Graduate School of Medicine, Yamaguchi) ,  TAKEHARA Tetsuo (Study Group on New Liver Cancer Therapies) ,  TAKEHARA Tetsuo (Osaka Univ. Graduate School of Medicine, Osaka) ,  UENO Yoshiyuki (Study Group on New Liver Cancer Therapies) ,  UENO Yoshiyuki (Tohoku Univ. Graduate School of Medicine, Sendai) ,  HIROISHI Kazumasa (Study Group on New Liver Cancer Therapies) ,  HIROISHI Kazumasa (Showa Univ. School of Medicine, Tokyo) ,  NISHIGUCHI Shuhei (Study Group on New Liver Cancer Therapies) ,  NISHIGUCHI Shuhei (Hyogo Coll. Medicine, Kakogawa) ,  MORIWAKI Hisataka (Study Group on New Liver Cancer Therapies) ,  MORIWAKI Hisataka (Gifu Univ. Graduate School of Medicine, Gifu) ,  YAMAMOTO Kazuhide (Study Group on New Liver Cancer Therapies) ,  YAMAMOTO Kazuhide (Okayama Univ. Graduate School of Medicine, Okayama) ,  SATA Michio (Study Group on New Liver Cancer Therapies) ,  SATA Michio (Kurume Univ. School of Medicine, Kurume) ,  OBI Shuntaro (Study Group on New Liver Cancer Therapies) ,  OBI Shuntaro (Kyoundo Hospital, Tokyo)
資料名： Hepatology Research  (Hepatology Research)
巻： 42  号： 6  ページ： 523-542  発行年： 2012年06月 
JST資料番号： W1284A  ISSN： 1386-6346  資料種別： 逐次刊行物 (A)
記事区分： 解説  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： 「肝細胞癌治療用の新規抗癌剤使用に関するガイドライン」は,「...

シソーラス用語： ヒト ,...
準シソーラス用語： Child-Pugh分類 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1121945&from=J-GLOBAL&jstjournalNo=W1284A") }}

分類 (2件)： 消化器の腫よう  (GH04000D) ,  腫ようの薬物療法  (GE03032C)

物質索引 (1件)： ソラフェニブ

引用文献 (35件)：

• LLOVET, JM. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359, 378-390
• CHENG, AL. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009, 10, 25-34
• KUDO, M. Treatment Strategy for HCC Cases Refractory for TACE. Hepatocelluar Carcinoma Practice Manual. 2010, 118-121
• Bayer Heathcare. Nexavar^【○!R】 adverse reaction reports liver injury and interstitial pulmonary disease. 2010
• ABOU-ALFA, GK. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006, 24, 4293-4300

タイトルに関連する用語 (4件)： 肝細胞癌 ,  治療 ,  抗癌剤 ,  ガイドライン